Bae Hyun W. bought KAPA

September 16, 2025 · Form 4 insider transaction

Bae Hyun W. bought 10,000 shares of Kairos Pharma, Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 98 days after the transaction.

Direction
Acquired (buy-side)
Shares
10,000
Price
$0.00
Total value
N/A
Role
SecurityCOMMON STOCK
Transaction codeA: Grant or award
Transaction dateSeptember 16, 2025
Filing dateDecember 23, 2025
Shares owned after54,286
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents 10,000 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan (the "Plan"). The 10,000 RSUs were granted on September 16, 2024, in conjunction with the Issuer's initial public offering (IPO), and vest annually in three substantially equal installments commencing on the anniversary date of the IPO.; Consists of (i) 47,620 shares of common stock and (ii) 6,666 RSUs which remain subject to vesting.

View the original Form 4 on SEC EDGAR